Citadel Advisors
CYRX icon

Citadel Advisors’s CryoPort CYRX Stock Holding History

Citadel Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
84,700
+51,300
+154% +$658K ﹤0.01% 7503
2026
Q1 		$277K Sell
33,400
-1,000
-3% -$9.03K ﹤0.01% 10656
2025
Q4 		$330K Sell
34,400
-117,700
-77% -$1.11M ﹤0.01% 9933
2025
Q3 		$1.44M Buy
152,100
+26,200
+21% +$221K ﹤0.01% 6751
2025
Q2 		$939K Buy
125,900
+9,100
+8% +$56.5K ﹤0.01% 7246
2025
Q1 		$710K Buy
116,800
+112,400
+2,555% +$778K ﹤0.01% 7710
2024
Q4 		$34.2K Sell
4,400
-31,100
-88% -$232K ﹤0.01% 12751
2024
Q3 		$288K Buy
35,500
+31,700
+834% +$259K ﹤0.01% 9419
2024
Q2 		$26.3K Sell
3,800
-9,600
-72% -$129K ﹤0.01% 12397
2024
Q1 		$237K Buy
13,400
+5,800
+76% +$91.8K ﹤0.01% 9965
2023
Q4 		$118K Sell
7,600
-27,200
-78% -$355K ﹤0.01% 10730
2023
Q3 		$477K Sell
34,800
-7,300
-17% -$107K ﹤0.01% 8161
2023
Q2 		$726K Buy
42,100
+1,000
+2% +$20.5K ﹤0.01% 7116
2023
Q1 		$986K Sell
41,100
-79,200
-66% -$1.72M ﹤0.01% 6813
2022
Q4 		$2.09M Sell
120,300
-41,400
-26% -$873K ﹤0.01% 5410
2022
Q3 		$3.94M Sell
161,700
-46,400
-22% -$1.6M ﹤0.01% 4278
2022
Q2 		$6.45M Buy
208,100
+102,800
+98% +$2.73M ﹤0.01% 3346
2022
Q1 		$3.68M Sell
105,300
-49,600
-32% -$1.88M ﹤0.01% 4778
2021
Q4 		$9.16M Buy
154,900
+69,400
+81% +$4.8M ﹤0.01% 3221
2021
Q3 		$5.69M Buy
85,500
+4,100
+5% +$253K ﹤0.01% 4062
2021
Q2 		$5.14M Sell
81,400
-44,600
-35% -$2.51M ﹤0.01% 4365
2021
Q1 		$6.55M Buy
126,000
+19,500
+18% +$1.19M ﹤0.01% 3715
2020
Q4 		$4.67M Buy
106,500
+6,000
+6% +$286K ﹤0.01% 3815
2020
Q3 		$4.76M Buy
100,500
+85,500
+570% +$3.46M ﹤0.01% 3240
2020
Q2 		$454K Buy
15,000
+2,000
+15% +$44.5K ﹤0.01% 7261
2020
Q1 		$222K Buy
+13,000
New +$228K ﹤0.01% 7837

Other funds holding CYRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Citadel Advisors's CYRX Position: Q2 2026 in Review

Citadel Advisors reduced its CryoPort (CYRX) stake by 15% in Q2 2026, selling an estimated $352K and leaving 155,768 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #6110.

Citadel Advisors first reported a position in CYRX in Q2 2018 and has held it in 28 quarters since. The position peaked at $12.7M in Q1 2021. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Citadel Advisors held 155,768 shares of CryoPort worth $2.45M as of Q2 2026.
  • Citadel Advisors sold 27,410 CryoPort shares in Q2 2026, an estimated $352K.
  • CryoPort made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6110 holding.
  • Citadel Advisors first reported a position in CryoPort in Q2 2018 and has held it in 28 quarters since.
  • Citadel Advisors's CryoPort position peaked at $12.7M in Q1 2021.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.